Evidence map›Paper›PMID 32574505›Full record

Trial reportAmerican journal of respiratory and critical care medicine2020

Novel Therapeutic Approaches for Pulmonary Manifestations of Systemic Sclerosis.

Justin K Lui, Nicholas A Bosch, Kari R Gillmeyer, Christine C Reardon

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Justin K LuiSection of Pulmonary, Allergy, Sleep and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-4745-3766
Nicholas A BoschSection of Pulmonary, Allergy, Sleep and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts.ORCID 0000-0001-7161-5254
Kari R GillmeyerSection of Pulmonary, Allergy, Sleep and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-5333-259X
Christine C ReardonSection of Pulmonary, Allergy, Sleep and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts.

Funding

BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
Determining disparities in treatment of pulmonary arterial hypertension nationallyF32HL149236 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILLMEYER, KARI · 2019 to 2020
$157k
Normalizing vasopressor dose to standardize vasopressors practice in septic shockF32GM133061 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOSCH, NICHOLAS A · 2019 to 2021
$101k
NHLBI NIH HHS F32 HL149236NHLBI NIH HHS T32 HL007035NIGMS NIH HHS F32 GM133061
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overFemaleHumansIndolesLungLung Diseases, InterstitialMaleMiddle AgedMycophenolic AcidProtein Kinase InhibitorsScleroderma, SystemicIndolesMycophenolic AcidnintedanibProtein Kinase Inhibitors

Identifiers

PMID32574505
PMCPMC7491395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.